Page results
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH Pain Management Centre is a nationally recognized centre of excellence for people with longstanding pain.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
While you're pregnant you will have a nominated professional lead which will be a midwife or an obstetrician.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH will play a vital role in a new respiratory virus study.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Trial of T-cell therapy for lung cancer begins at UCLH
File results
-
FOI/2024/0274 - Number of endoscopes at Trust
-
FOI/2024/0277 - Paediatric respiratory admission rates 2018-2023
-
FOI/2024/0279 - Social media management platforms and tools
-
FOI/2024/0283 - Cyber security/ cyber attack
-
FOI/2024/0285 - Private patient non-contractual tariffs
-
FOI/2024/0297 - Policy for parasitic infestation assessment and treatment of patients
-
FOI/2024/0302 - Mental health diagnosis for patients aged 11 to 25
-
FOI/2024/0301 - Nursing associates and trainee nursing associates policy
-
FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024
-
FOI/2024/0295 - MRI scanners at Trust 2019/2020 and 2022/24